...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: USA ZHCLF investors
6
Oct 28, 2022 09:26PM
2
Oct 28, 2022 10:15PM
3
Oct 29, 2022 08:17AM
2
Oct 29, 2022 11:18AM
5
Oct 29, 2022 03:45PM

RVXOT:

"From Zenith Capital Corp. MD&A:

As at July 31, 2022, we hold all 75,202,620 royalty preferred shares of Resverlogix. We, as the sole holder of the royalty preferred shares of Resverlogix, are entitled to dividends in the amount of 6-12% of Resverlogix’s Net Revenue, if any"

Presumably, this would only apply to "ZHCLF" shares trading on the OTC market. It would not apply to Zenith shares acquired directly from Zenith post SPINCO 2013.

Would it be a problem distinguishing between the two sets of Zenith shares when it comes to issuing dividends? 

 

Koo

 

 

3
Oct 30, 2022 09:54AM

Oct 30, 2022 11:38AM
2
Oct 30, 2022 12:25PM
3
Oct 30, 2022 01:28PM
1
Oct 30, 2022 03:57PM
2
Oct 30, 2022 04:07PM

Oct 30, 2022 04:16PM

Oct 30, 2022 04:34PM
2
Oct 30, 2022 05:01PM

Oct 30, 2022 05:12PM
2
Oct 30, 2022 05:17PM

Nov 01, 2022 08:31AM
1
Nov 01, 2022 09:23AM
4
Nov 01, 2022 10:26AM
1
Nov 01, 2022 12:02PM
1
Nov 01, 2022 03:10PM
4
Nov 01, 2022 04:24PM
5
Nov 01, 2022 05:15PM
2
Nov 01, 2022 05:57PM
3
Nov 01, 2022 07:26PM
2
Nov 02, 2022 11:47AM
1
Nov 02, 2022 11:56AM
2
Nov 02, 2022 12:01PM
4
Nov 02, 2022 02:36PM
4
Nov 02, 2022 03:33PM
1
Nov 02, 2022 09:41PM
5
Nov 02, 2022 10:18PM
1
Nov 04, 2022 12:05PM
3
Nov 04, 2022 12:33PM
1
Nov 04, 2022 01:16PM
Share
New Message
Please login to post a reply